Renal Microvascular Disease Predicts Renal Function in Diabetes

REFERENCES

• Bellasi A, Furamosca E, Ratti C. Arterial stiffness in chronic kidney disease: The usefulness of a marker of vascular damage. Int J Nephrol. 2011;2011:754832.
   Google Scholar
• Takenaka T, Hoshi H, Kato N, . Cardio-ankle vascular index to screen cardiovascular disease in patients with end-stage renal disease. J Atheroscler Thromb. 2008;15(6):339–344.
   PubMed Web of Science ®Google Scholar
• Paraskevas KI, Kotsikoris I, Koupidis SA, . Ankle-brachial index: A marker of both peripheral arterial disease and systemic atherosclerosis as well as a predictor of vascular events. Angiology. 2010;61:521–523.
   PubMed Web of Science ®Google Scholar
• Hefferuan KS, Kuvir JT, Sarnak MK, . Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2011;26(8):2515–2521.
   PubMed Web of Science ®Google Scholar
• Bellasi A, Raggi P. Vascular calcification in chronic kidney disease: Usefulness of vascular damage. J Nephrol. 2011;24(Suppl. 18):S11–S15.
   PubMedGoogle Scholar
• Marin M, Manez S. Pharmacological interventions on asymmetric dimethylarginine, a clinical marker of vascular disease. Curr Med Chem. 2011;18:714–724.
   PubMed Web of Science ®Google Scholar
• Anderssohn M, Schwedhelm E, Luneburg N, . Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: An intriguing interaction with diabetes mellitus. Diab Vasc Dis Res. 2010;7:105–118.
   PubMed Web of Science ®Google Scholar
• Sniderman A, MoQueen M, Contois J, . Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? J Clin Lipidol. 2010;4(1):152–155.
   PubMedGoogle Scholar
• Nilsson K, Gustafson L, Hultberg B. Plasma homocysteine—A marker of vascular disease in elderly patients with mental illness. Clin Biochem. 2010;43(13–14):1056–1059.
   PubMed Web of Science ®Google Scholar
• Abdellaoui A, Al-Khaffaf H. C-reactive protein (CRP) as a marker in peripheral vascular disease. Eur J Vasc Endovasc Surg. 2007;34:18–22.
   PubMed Web of Science ®Google Scholar
• Kalea AZ, Schmidt AM, Hudson BI. RAGE: A novel biological and genetic marker of vascular disease. Clin Sci. 2009;116:621–637.
   PubMed Web of Science ®Google Scholar
• Futrakul N, Futrakul P. Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes. Int J Vasc Med. 2011;2011:971524, doi:10.1155/2011/971524.
   Google Scholar
• Futrakul N, Butthep P, Futrakul P. Altered vascular homeostasis in chronic kidney disease. Clin Hemorheol Microcirc. 2008;38:201–207.
   PubMed Web of Science ®Google Scholar
• Horvath B, Hegedus D, Szapary L, . Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases. Exp Clin Cardiol. 2004;9:31–34.
   PubMedGoogle Scholar
• Del Papa N, Colombo G, Iracchiolla N, . Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum. 2004;50:1296–1304.
   PubMed Web of Science ®Google Scholar
• Futrakul N, Butthep P, Futrakul P, . Glomerular endothelial dysfunction in type 2 diabetes mellitus. Ren Fail. 2006;28:523–524.
   PubMed Web of Science ®Google Scholar
• Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: A potential prognostic marker for atherosclerotic vascular disease. Hypertension. 2006;48:180–186.
   PubMed Web of Science ®Google Scholar
• Garg JP, Bahris GL. Microalbuminuria: Marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med. 2002;7:35–43.
   PubMed Web of Science ®Google Scholar
• Futrakul N, Sridama V, Futrakul P. Microalbuminuria—A biomarker for renal microvascular disease. Ren Fail. 2009;31:140–143.
   PubMed Web of Science ®Google Scholar
• Lindenmeyer MT, Kaetzler M, Boucherot A, . Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol. 2007;18:1765–1776.
   PubMed Web of Science ®Google Scholar
• Futrakul N, Kittikowit W, Yenrudi S. Reduced endothelial factor VIII staining in renal microcirculation correlates with hemodynamic alteration in nephrosis. Ren Fail. 2003;25:757–746.
   Web of Science ®Google Scholar
• Bortoloso E, Dol Prete P, Veotra MB, . Quantitative and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes. Eur J Endocrinol. 2004;150:799–807.
   PubMed Web of Science ®Google Scholar
• Yenrudi S, Laohapaibul A, Kittikowit W, . A correlation between renal morphology and renal circulation in pediatric nephrotic syndrome. Ren Fail. 2001;23:85–90.
   PubMed Web of Science ®Google Scholar
• Futrakul N, Yenrudi S, Sensirivatana R, . Peritubular capillary flow determines tubulointerstitial disease in idiopathic nephrotic syndrome. Ren Fail. 2000;22:329–335.
   PubMed Web of Science ®Google Scholar
• Bohle AC, Mackensen-Haen S, Wehrmann M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res. 1996;192:191–195.
   Google Scholar
• Kang DH, Kanellis J, Hugo C, . Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol. 2002;13:806–816.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Kang DH, Ohashi R, . Tubulointerstitial disease: Role of ischemia and microvascular disease. Curr Opin Nephrol Hypertens. 2003;12:233–241.
   PubMed Web of Science ®Google Scholar
• Futrakul P, Sitprija V, Yenrudi S, . Glomerular endothelial dysfunction determines disease progression: A hypothesis. Am J Nephrol. 1997;17:133–140.
   Web of Science ®Google Scholar
• Futrakul P, Poshyachinda M, Yenrudi S, . Intrarenal hemodynamic abnormality in severe form of glomerulonephritis: Therapeutic benefit with vasodilator. J Med Assoc Thai. 1992;75:375–385.
   PubMedGoogle Scholar
• Futrakul P, Yenrudi S, Futrakul N, . Tubular function and tubulointerstitial disease. Am J Kidney Dis. 1999;33:886–891.
   PubMed Web of Science ®Google Scholar
• Galesic K, Sabljar-Matovinovic M, Tomic M, . Renal vascular resistance in glomerular diseases—Correlation of resistance index with biopsy findings. Coll Antropol. 2004;28:667–674.
   PubMedGoogle Scholar
• Futrakul N, Futrakul P. A mildly altered vascular homeostasis in early stage of CKD. Ren Fail. 2009;31:538–543.
   PubMed Web of Science ®Google Scholar
• Futrakul N, Butthep P, Chunhakan S, . Vascular homeostasis in early (normoalbuminuric) type 2 diabetic nephropathy. Asian Biomed. 2010;4:987–990.
   Web of Science ®Google Scholar
• Natarajan R, Bai W, Lanting L, . Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cell. Am J Physiol. 1997;273:H2224–H2231.
   PubMed Web of Science ®Google Scholar
• Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol. 2000;279:L1005–L1028.
   PubMed Web of Science ®Google Scholar
• Vesquez-Viver J, Kalyanaraman S, Martasek P, . Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci USA. 1998;95:9220–9225.
   PubMed Web of Science ®Google Scholar
• Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int. 1989;35:1093–1106.
   PubMed Web of Science ®Google Scholar
• Zinman B, Hanley AJ, Harris SB, . Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab. 1999;84:272–278.
   PubMed Web of Science ®Google Scholar
• Thomas MC, Tikellis C, Burno WM, . Interactions between renin angiotensin system and advanced glycation in the kidney. J Am Soc Nephrol. 2005;16:2976–2984.
   PubMed Web of Science ®Google Scholar
• Berg AH, Scherer PE. Odipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96:939–949.
   PubMed Web of Science ®Google Scholar
• Malek AM, Izumo I. Molecular aspects of signal transduction of shear stress in the endothelial cell. J Hypertens. 1994;12:989–1000.
   PubMed Web of Science ®Google Scholar
• Sachse A, Wolf G. Angiotensin II induced reactive oxygen species and the kidney. J Am Soc Nephrol. 2007;18:2439–2446.
   PubMed Web of Science ®Google Scholar
• Futrakul N, Butthep P. Early detection of endothelial injury and dysfunction in conjunction with the correction of hemodynamic maladjustment can effectively restore renal function in type 2 diabetic nephropathy. Clin Hemorheol Microcirc. 2006;34:373–381.
   PubMed Web of Science ®Google Scholar
• Futrakul N, Kulaputana O, Futrakul P, . Enhanced peritubular capillary flow and renal function can be accomplished in normoalbuminuric type 2 diabetic nephropathy. Ren Fail. 2011;33(3):312–315.
   PubMed Web of Science ®Google Scholar
• Ritt M, Ott C, Raff U, . Renal vascular endothelial function in hypertensive patients with type 2 diabetes. Am J Kidney Dis. 2009;53:281–289.
   PubMed Web of Science ®Google Scholar
• Karalliedde J, Gnudi L. Future strategies to prevent renal microvascular disease complications in diabetes. Future Cardiol. 2008;4:77–83.
   PubMedGoogle Scholar